Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Board decides not to add 3‑MCC deficiency to Washington newborn screening panel
Summary
After technical advisory committee review and cost‑benefit analysis, the State Board of Health voted not to add 3‑methylcrotonyl‑CoA carboxylase (3‑MCC) deficiency to the statewide newborn screening panel, citing limited expected public health benefit and uncertain long‑term infrastructure and cost implications.
The Washington State Board of Health determined on Jan. 13 not to add 3‑MCC deficiency to the state newborn screening panel following a technical advisory committee review and department analysis.
Board staff and the advisory technical committee presented the condition’s characteristics — an estimated prevalence of about 1 in 40,000, a majority of cases that are asymptomatic, and a small subset (estimated…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
